| Product NDC: | 0781-1053 |
| Proprietary Name: | Bupropion Hydrochloride |
| Non Proprietary Name: | Bupropion Hydrochloride |
| Active Ingredient(s): | 75 mg/1 & nbsp; Bupropion Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-1053 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075584 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000207 |
| Package NDC: | 0781-1053-31 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0781-1053-31) |
| NDC Code | 0781-1053-31 |
| Proprietary Name | Bupropion Hydrochloride |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0781-1053-31) |
| Product NDC | 0781-1053 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bupropion Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20000207 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |